Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer

Nutrition and Cancer

Volumn 35, Issue 2, 1999, Pages 127-129

  O'Gorman, Patricia ^a   McMillan, Donald C ^a   McArdle, Colin S ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ADULT; AGED; APPETITE; ARTICLE; CACHEXIA; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HUMAN; INFLAMMATION; MALE; PANCREAS CANCER; SKINFOLD THICKNESS; STOMACH CANCER; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0033493296     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC352_5     Document Type: Article

References (14)

1. DeWys, WD, Begg, C, Lavin, PT, Band, PR, Bennett, JM, et al.: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69, 491-497, 1980.
2. Yates, JW, Chalmers, B, and McKegney, FP: Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45, 2220-2224, 1980.
3. Kern, KA, and Norton, JA: Cancer cachexia. J Parent Enteral Nutr 12, 286-298, 1988.
4. Ovesen, L, Hannibal, J, and Mortensen, EL: The interrelationship of weight loss, dietary intake and quality of life in ambulatory patients with cancer of the lung, breast and ovary. Nutr Cancer 19, 159-167, 1993.
5. Grosvenor, M, Bulcavage L, and Chlebowski, RT: Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administration. Cancer 63, 330-334, 1989.
6. O'Gorman, P, McMillan, DC, and McArdle, CS: Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer 32, 76-80, 1998.
7. McMillan, DC, Simpson, JM, Preston, T, Watson, WS, Fearon, KCH, et al.: Effect of megestrol acetate on weight loss, body composition and blood screen of gastrointestinal cancer patients. Clin Nutr 13, 85-89, 1994.
8. Goransson, J, Jonsson, S, and Lasson, A: Pre-operative plasma levels of C-reactive protein, albumin and various plasma protease inhibitors for the pre-operative assessment of operability and recurrence in cancer surgery. Eur J Surg Oncol 22, 607-617, 1996.
9. McMillan, DC, Preston, T, Watson, WS, Simpson, JM, Fearon, KCH, et al.: The relationship between weight loss, reduction of body cell mass and the inflammatory response in cancer patients. Br J Surg 81, 1011-1014, 1994.
10. Falconer, JS, Fearon, KCH, Plester, CE, Ross, JA, and Carter, DC: Cytokines, the acute phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 219, 325-331, 1994.
11. Scott, HR, McMillan, DC, Crilley, A, McArdle, CS, and Milroy, R: The relationship between weight loss and interleukin-6 in non-small cell lung cancer. Br J Cancer 73, 1560-1562, 1996.
12. Karnofsky, DA, Ableman, WH, Craver, LF, and Burchenal, JH: The use of nitrogen mustard in the palliative treatment of carcinoma. Cancer 1, 634-656, 1948.
13. McMillan, DC, Wigmore, SJ, Fearon, KCH, O'Gorman, P, Wright, CE, et al.: A randomised study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer 79, 495-500, 1998.
14. Wigmore, SJ, Plester, CE, Richardson, RA, and Fearon, KCH: Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75, 106-109, 1997.